EPCAM and malignant colon neoplasm: This protein is overexpressed in 80–100% of colorectal cancers [47] and is, in fact, used for several diagnostic and therapeutic tools, such as the anti-EpCAM antibody described by Liao et al. [48] for colon cancer treatment.